SVA Share Price

Open 0.21 Change Price %
High 0.21 1 Day -0.01 -4.76
Low 0.18 1 Week -0.02 -9.09
Close 0.20 1 Month 0.01 5.26
Volume 86315 1 Year -0.10 -33.33
52 Week High 0.32
52 Week Low 0.14
SVA Important Levels
Resistance 2 0.23
Resistance 1 0.22
Pivot 0.20
Support 1 0.18
Support 2 0.17
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
XOP 0.03 50.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
VRS 0.02 100.00%
VRS 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
AFF 0.08 60.00%
AFF 0.08 60.00%
More..
CVE Canada Top Losers Stocks
MOO 0.00 -100.00%
DVC-H 0.03 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Sernova Corp (CVE: SVA)

SVA Technical Analysis 1.5
As on 25th Sep 2017 SVA Share Price closed @ 0.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.24 & Buy for SHORT-TERM with Stoploss of 0.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for September
1st Target up-side 0.25
2nd Target up-side 0.28
3rd Target up-side 0.31
1st Target down-side 0.17
2nd Target down-side 0.14
3rd Target down-side 0.11
SVA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sernova.com
SVA Address
SVA
700 Collip Circle
Suite 114
London, ON N6G 4X8
Canada
Phone: 519-858-5184
Fax: 519-858-5099
SVA Latest News
Interactive Technical Analysis Chart Sernova Corp ( SVA CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sernova Corp
SVA Business Profile
Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.